Compare APC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APC | OPK |
|---|---|---|
| Founded | 2025 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.0M | 921.2M |
| IPO Year | N/A | 2011 |
| Metric | APC | OPK |
|---|---|---|
| Price | $19.00 | $1.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $21.75 | $1.60 |
| AVG Volume (30 Days) | 161.7K | ★ 2.3M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | ★ 10.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $4.47 | N/A |
| Revenue Next Year | $4.20 | $4.24 |
| P/E Ratio | $25.80 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.08 | $0.98 |
| 52 Week High | $21.72 | $1.60 |
| Indicator | APC | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 43.70 | 82.58 |
| Support Level | $17.43 | $1.25 |
| Resistance Level | $19.43 | $1.52 |
| Average True Range (ATR) | 0.81 | 0.06 |
| MACD | -0.22 | 0.03 |
| Stochastic Oscillator | 12.33 | 89.41 |
Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.